Allison Chambliss * USC Profiles

Allison Chambliss, PhD, DABCC

Title(s)	Assistant Professor of Clinical Pathology
vCard	Download vCard

Biography

Education and Training

Virginia Tech, Blacksburg, VA	B.S.	05/2009	Chemical Engineering, Biomedical Engineering
Johns Hopkins University, Baltimore, MD	Ph.D.	08/2014	Chemical & Biomolecular Engineering
Johns Hopkins Hospital, Baltimore, MD	Clinical Fellowship	08/2016	Pathology, Clinical Chemistry

Overview

Dr. Chambliss is an assistant professor of clinical pathology at the Keck School of Medicine of the University of Southern California in Los Angeles, CA. She is the director of clinical chemistry and point-of-care testing at the Los Angeles County + USC Medical Center. She has research interests in validating new diagnostics and biomarkers.

Interests

clinical chemistry, point of care testing, diagnostics, blood testing, toxicology, biomarkers, procalcitonin, sepsis, pharmacogenetics, drug testing, endocrinology

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.

List All | Timeline

Furey C, Buxbaum J, Chambliss AB. A review of biomarker utilization in the diagnosis and management of acute pancreatitis reveals amylase ordering is favored in patients requiring laparoscopic cholecystectomy. Clin Biochem. 2019 Dec 31. PMID: 31899279.

View in: PubMed
Chambliss AB, Hayden J, Colby JM. Evaluation of procalcitonin immunoassay concordance near clinical decision points. Clin Chem Lab Med. 2019 Aug 27; 57(9):1414-1421. PMID: 30763263.

View in: PubMed
Chambliss AB, Butler-Wu SM, Dien Bard J. Diagnosis and Management of Sepsis and Blood Stream Infections. J Appl Lab Med. 2019 01; 3(4):525-526. PMID: 31639719.

View in: PubMed
Chambliss AB, Butler-Wu SM, Dien Bard J. Breaking Down Barriers in Laboratory Medicine. J Appl Lab Med. 2019 01; 3(4):735-736. PMID: 31639743.

View in: PubMed
Chambliss AB. Embracing Procalcitonin for Antimicrobial Stewardship. J Appl Lab Med. 2019 01; 3(4):712-715. PMID: 31639737.

View in: PubMed
Chambliss AB, Resnick M, Petrides AK, Clarke WA, Marzinke MA. Rapid screening for targeted genetic variants via high-resolution melting curve analysis. Clin Chem Lab Med. 2017 Mar 01; 55(4):507-516. PMID: 27732553.

View in: PubMed
Chambliss AB, Chan DW. Precision medicine: from pharmacogenomics to pharmacoproteomics. Clin Proteomics. 2016; 13:25. PMID: 27708556.

View in: PubMed
Shah MY, Martinez-Garcia E, Phillip JM, Chambliss AB, Popovic R, Ezponda T, Small EC, Will C, Phillip MP, Neri P, Bahlis NJ, Wirtz D, Licht JD. MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents. Oncogene. 2016 11 10; 35(45):5905-5915. PMID: 27109101.

View in: PubMed
Chambliss AB, Füzéry AK, Clarke WA. Quantification of Hydroxychloroquine in Blood Using Turbulent Flow Liquid Chromatography-Tandem Mass Spectrometry (TFLC-MS/MS). Methods Mol Biol. 2016; 1383:177-84. PMID: 26660186.

View in: PubMed
Kim DH, Chambliss AB, Wirtz D. The multi-faceted role of the actin cap in cellular mechanosensation and mechanotransduction. Soft Matter. 2013 Jun 21; 9(23):5516-5523. PMID: 23930135.

View in: PubMed
Chambliss AB, Wu PH, Chen WC, Sun SX, Wirtz D. Simultaneously defining cell phenotypes, cell cycle, and chromatin modifications at single-cell resolution. FASEB J. 2013 Jul; 27(7):2667-76. PMID: 23538711.

View in: PubMed
Chambliss AB, Khatau SB, Erdenberger N, Robinson DK, Hodzic D, Longmore GD, Wirtz D. The LINC-anchored actin cap connects the extracellular milieu to the nucleus for ultrafast mechanotransduction. Sci Rep. 2013; 3:1087. PMID: 23336069.

View in: PubMed